伴发性失眠和睡眠呼吸暂停:科米萨
1Unidade de Sono, Centro Cardiovascular da Universidade, de Lisboa (CCUL@RISE), Faculdade de Medicina da, Universidade de Lisboa, Av. Professor Egas Moniz, 1649-028 Lisboa, Portugal.
Dental clinics of North America
|June 15, 2024
概括
伴随性失眠和睡眠呼吸暂停 (COMISA) 与压力和心脏风险有关. 了解这种联系是新疗法的关键,如下器械,以管理这些常见的睡眠障碍.
科学领域:
- 睡眠医学 睡眠医学
- 心脏病学 心脏病学
- 内部医学 内部医学
背景情况:
- 伴随性失眠和睡眠呼吸暂停 (COMISA) 代表了普遍存在的睡眠障碍的融合.
- 失眠和睡眠呼吸暂停都独立地与增加的压力和心脏代谢风险有关.
- 了解COMISA对于阐明潜在的病理生理路径至关重要.
研究的目的:
- 为COMISA的流行病学方面提供全面的概述.
- 审查与COMISA相关的临床发现.
- 探索COMISA背后的机制,并讨论治疗策略.
主要方法:
- 文献综述和对COMISA现有研究的综合.
- 流行病学数据分析.
- 临床案例研究审查.
主要成果:
- COMISA与压力水平和心脏代谢风险因素的显著增加有关.
- 正在确定将失眠和睡眠呼吸暂停联系在一起的特定病理生理机制.
- 牙牙学方法,特别是下前进装置,显示出有希望的结果.
结论:
- 由于它与压力和心脏代谢疾病有关,COMISA对健康造成了重大负担.
- 需要对COMISA机制进行进一步的研究,以完善治疗干预措施.
- 部推进装置为管理COMISA提供了一个可行的治疗选择.
相关概念视频
Sleep Apnea
143
Sleep apnea is a condition where breathing stops intermittently during sleep, often leading to significant health issues. Each episode can last from 10 to 20 seconds or more and is frequently accompanied by a brief arousal from sleep. This disturbance, largely unnoticed by the individual, can lead to severe daytime fatigue. Commonly, individuals seek help after being informed by their partners about loud snoring and noticeable breathing pauses during sleep.
The condition is more prevalent among...
The condition is more prevalent among...
143
Management of Insomnia
244
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
244
Insomnia
82
Insomnia is a prevalent sleep disorder characterized by difficulty falling asleep, frequent awakenings during the night, and waking up too early without being able to return to sleep. People with insomnia often experience these disruptions at least three nights a week for at least one month. Chronic insomnia, which lasts for at least three months, can lead to increased anxiety, which in turn can worsen sleep difficulties, creating a cycle of sleeplessness and stress.
Multiple factors contribute...
Multiple factors contribute...
82
Substance Use Disorders Affecting Sleep
164
Substance use disorders involve a pattern of using drugs more extensively than intended and continuing use despite harmful consequences. This includes legal substances like alcohol and nicotine, as well as illegal drugs. These disorders often involve both physical and psychological dependence, reflecting compulsive use of substances that significantly alter thoughts, feelings, and behaviors, contributing to a major public health issue.
Understanding the concepts of physical dependence,...
Understanding the concepts of physical dependence,...
164
Sleepwalking and Sleep Talking
142
Somnambulism, commonly known as sleepwalking, involves individuals engaging in activities ranging from simple walking to more complex behaviors such as driving. Sleepwalking typically occurs during the slow-wave sleep stages 3 and 4 early in the night when the person is not dreaming, contradicting the myth that sleepwalkers are acting out their dreams.
Factors that increase the likelihood of sleepwalking include sleep deprivation and alcohol consumption. Contrary to common beliefs, it is safe...
Factors that increase the likelihood of sleepwalking include sleep deprivation and alcohol consumption. Contrary to common beliefs, it is safe...
142
Sedatives and Hypnotics Drugs: Miscellaneous Agents
168
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
168


